Biovica International AB (publ)

Stockholm Stock Exchange BIOVIC-B.ST

Biovica International AB (publ) Dividends Paid for the year ending April 30, 2024: USD 0.00

Biovica International AB (publ) Dividends Paid is USD 0.00 for the year ending April 30, 2024, a 0.00% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Biovica International AB (publ) Dividends Paid for the year ending April 30, 2023 was USD 0.00, a 0.00% change year over year.
Biovica International AB (publ) Dividends Paid for the year ending April 30, 2022 was USD 0.00, a 0.00% change year over year.
Biovica International AB (publ) Dividends Paid for the year ending April 30, 2021 was USD 0.00, a 0.00% change year over year.
Biovica International AB (publ) Dividends Paid for the year ending April 30, 2020 was USD 0.00, a 0.00% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Stockholm Stock Exchange: BIOVIC-B.ST

Biovica International AB (publ)

CEO	Mr. Anders Rylander
IPO Date	March 29, 2017
Location	Sweden
Headquarters	Dag HammarskjOelds vAeg 54B
Employees	27
Sector	Healthcare
Industries Biotechnology Clinical Trials Pharmaceuticals

Description

Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.

Key trends

Past 5 years